SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-13-000812
Filing Date
2013-01-14
Accepted
2013-01-14 10:22:21
Documents
1
Period of Report
2013-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 6550
  Complete submission text file 0001179110-13-000812.txt   7917
Mailing Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703
Business Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703 919 474 0020
TRANZYME INC (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 5001 SOUTH MIAMA BOULEVARD SUITE 300 DURHAM NC 27703
Business Address
Stanley Rhonda L. (Reporting) CIK: 0001566045 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35119 | Film No.: 13526839